En populationsfarmakokinetisk analyse omfattende 102 patienter påviste lav interpersonlig (CV=21%) og intrapersonlig (CV=12%) variabilitet i busulfan efter lægemiddeleksponering
Low inter (CV=21%) and intra (CV=12%) patient variability on busulfan exposure was demonstrated through a population pharmacokinetic analysis, performed on 102 patients.